A regulatory challenge arguing that the FDA's interpretation of 503A is too narrow is theoretically possible but faces long odds given the statute's plain language
James Grant of Michigan BCBS summarized the frustration: "We were wasting millions of dollars, and people did not even see true benefit." From an actuarial perspective, the math was devastating
Health plans should work alongside PBMs and GLP-1 manufacturers to drive down costs, unlock rebates to further mitigate cost challenges and enhance drug commercialization (e.g., joint production partnerships, marketing partnerships)
Emotional well-being is addressed through lessons and coaching in stress management, resilience, and strategies for avoiding emotional eating
Back Okunogbe, A, Nugent, R, Spencer, G, et al (Oct 2021) 'Economic impacts of overweight and obesity: current and future estimates for eight countries', British Medical Journal Global Health , 6/10, Back rskov, C, Bersani, M, Johnson, AH, et al (5 August 1989) 'Complete sequences of glucagon-like peptide-1 from human and pig small intestine', Journal of Biological Chemistry , 264/22, 12826-9
Furthermore, these treatments are not yet reimbursed by social security health system in France
